Corient Private Wealth’s ADMA Biologics ADMA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.41M | Buy |
77,416
+41,260
| +114% | +$751K | ﹤0.01% | 1261 |
|
|
2025
Q1 | $717K | Buy |
36,156
+564
| +2% | +$11.2K | ﹤0.01% | 1426 |
|
|
2024
Q4 | $610K | Sell |
35,592
-1,038
| -3% | -$17.8K | ﹤0.01% | 1513 |
|
|
2024
Q3 | $732K | Buy |
36,630
+4,291
| +13% | +$85.8K | ﹤0.01% | 1528 |
|
|
2024
Q2 | $362K | Buy |
32,339
+1,540
| +5% | +$17.2K | ﹤0.01% | 1802 |
|
|
2024
Q1 | $203K | Buy |
30,799
+13
| +0% | +$86 | ﹤0.01% | 2088 |
|
|
2023
Q4 | $139K | Hold |
30,786
| – | – | ﹤0.01% | 2118 |
|
|
2023
Q3 | $110K | Hold |
30,786
| – | – | ﹤0.01% | 2007 |
|
|
2023
Q2 | $114K | Buy |
30,786
+13,293
| +76% | +$49.1K | ﹤0.01% | 1948 |
|
|
2023
Q1 | $57.9K | Hold |
17,493
| – | – | ﹤0.01% | 1913 |
|
|
2022
Q4 | $67.9K | Buy |
+17,493
| New | +$67.9K | ﹤0.01% | 1599 |
|